rs121913514
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
[Secondary mutation of c-kit/PDGFRα genotypes after imatinib mesylate therapy and its relationship with efficacy of sunitinib].
|
22932406 |
2012 |
rs121913523
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
[Secondary mutation of c-kit/PDGFRα genotypes after imatinib mesylate therapy and its relationship with efficacy of sunitinib].
|
22932406 |
2012 |
rs121913523
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
[Secondary mutation of c-kit/PDGFRα genotypes after imatinib mesylate therapy and its relationship with efficacy of sunitinib].
|
22932406 |
2012 |
rs121913513
|
|
C |
0.760 |
CausalMutation |
CLINVAR |
We have identified the first human melanoma cell line with an endogenous L576P mutation, the most common KIT mutation in melanoma ( approximately 30-40%).
|
19671763 |
2009 |
rs993022333
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
V559A and N822I double KIT mutant melanoma with predictable response to imatinib?
|
21159146 |
2011 |
rs1057519703
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Transcriptome sequencing of melanocytic nevi and melanomas from Grm1 transgenic mice to determine melanoma driver mutations.
|
24661573 |
2014 |
rs1057519703
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Transcriptome sequencing of melanocytic nevi and melanomas from Grm1 transgenic mice to determine melanoma driver mutations.
|
24661573 |
2014 |
rs1057519705
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Transcriptome sequencing of melanocytic nevi and melanomas from Grm1 transgenic mice to determine melanoma driver mutations.
|
24661573 |
2014 |
rs1057519706
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Transcriptome sequencing of melanocytic nevi and melanomas from Grm1 transgenic mice to determine melanoma driver mutations.
|
24661573 |
2014 |
rs1057519708
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Transcriptome sequencing of melanocytic nevi and melanomas from Grm1 transgenic mice to determine melanoma driver mutations.
|
24661573 |
2014 |
rs121913517
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Transcriptome sequencing of melanocytic nevi and melanomas from Grm1 transgenic mice to determine melanoma driver mutations.
|
24661573 |
2014 |
rs1057519703
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
The GIST of targeted therapy for malignant melanoma.
|
24531699 |
2014 |
rs1057519703
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
The GIST of targeted therapy for malignant melanoma.
|
24531699 |
2014 |
rs1057519705
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
The GIST of targeted therapy for malignant melanoma.
|
24531699 |
2014 |
rs1057519706
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
The GIST of targeted therapy for malignant melanoma.
|
24531699 |
2014 |
rs1057519708
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
The GIST of targeted therapy for malignant melanoma.
|
24531699 |
2014 |
rs121913517
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
The GIST of targeted therapy for malignant melanoma.
|
24531699 |
2014 |
rs121913513
|
|
C |
0.760 |
CausalMutation |
CLINVAR |
Sunitinib therapy for melanoma patients with KIT mutations.
|
22261812 |
2012 |
rs121913235
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Sunitinib therapy for melanoma patients with KIT mutations.
|
22261812 |
2012 |
rs121913235
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Sunitinib therapy for melanoma patients with KIT mutations.
|
22261812 |
2012 |
rs121913513
|
|
C |
0.760 |
CausalMutation |
CLINVAR |
Somatic activation of KIT in distinct subtypes of melanoma.
|
16908931 |
2006 |
rs121913512
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
Somatic activation of KIT in distinct subtypes of melanoma.
|
16908931 |
2006 |
rs121913517
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Somatic activation of KIT in distinct subtypes of melanoma.
|
16908931 |
2006 |
rs121913517
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Somatic activation of KIT in distinct subtypes of melanoma.
|
16908931 |
2006 |
rs1057519713
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Secondary c-Kit mutations confer acquired resistance to RTK inhibitors in c-Kit mutant melanoma cells.
|
23582185 |
2013 |